Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

View:
Post by Duster340 on Mar 08, 2024 10:17am

Lots of Questions

but no answers = uncertainty and a lower stock price
Comment by Harper75 on Mar 08, 2024 10:32am
IMO the total silence from Antibe leadership is astounding.   
Comment by Montana5 on Mar 08, 2024 5:29pm
Insider buys March 6/7: Curtis 15,000 shares @ $.52 Legault 20,000 shares @ $.50 Stauffer 24,000 shares @ $.40 USD Not exactly mortgaging the house, but better than nothing. Curious as to where they are coming up with $24 million USD to settle with Nuance and the timing of that payment. Makes no sense doing a financing at the current share price. Hopefully they can come with a viable option. Open ...more  
Comment by MrMugsy on Mar 08, 2024 8:07pm
Still here -  trying to understand all the options and what it takes to get P2 completed.
Comment by Duster340 on Mar 09, 2024 12:08pm
all options maybe running out, if payment to nuance is do within weeks of the ruling that means they will be broke no money for P2 and not even enough cash left to keep the lights on at the office. i think the insider buying was just an effort to stabilize the stock price while they try and find someone to finance them, if the stock were to collapses down to a dime financing would be impossible.
Comment by Montana5 on Mar 09, 2024 3:13pm
Maybe with the way ATE respectfully waived the white flag on the arbitration, could it be possible that Nuance might be agreeable to a graduated payback that might benefit the completion of P2 and the potential of securing a new partnership agreement? We know the amount of the settlement, but under what terms and conditions? I'm hoping ATE will be providing more information this week with ...more  
Comment by Duster340 on Mar 09, 2024 5:32pm
anything is possible but is nuance willing to take that risk unlikely, if they did agree to a deal that kicks payment down the road antibe will burn through the cash with P2 but what if otena is unsuccessful ATE will be bankrupt and nuance will also lose out on there 24M that they have in the bag right now.
Comment by MrMugsy on Mar 09, 2024 5:51pm
Many unknowns about how this moves forward. Nuance is an unsecured creditor but I don't know what happens after that. I think we're waiting for them to chat first. I don't know what follows.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities